Date: November 3, 2026 CorVel Corporation
Date: November 3, 2026 CorVel Corporation ─────────────────────────────────────────────────── 5128 Apache Plume Road Suite 400 Fort Worth, TX 76109 FOR IMMEDIATE RELEASE Contact: Melissa Storan Phone: 949-851-1473 www.corvel.com
CorVel Announces Revenues and Earnings FORT WORTH, Texas, November 3, 2026 — CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended September 30, 2026. Revenues for the quarter were $267 million, an increase from $240 million in the September quarter of 2025. Earnings per share for the quarter were $0.67, compared to $0.54 in the same quarter of the prior year. Revenues for the six months ended September 30, 2026 were $527 million, an increase from $474 million for the six months ended September 30, 2025. Earnings per share for the six months ended September 30, 2026 were $1.31, compared to $1.06 during the six months ended September 30, 2025. Second Quarter Fiscal Year 2027 Highlights • Revenue increased 11% to $267 million, compared to second quarter of fiscal year 2026. • Gross profit increased 24% to $72.3 million, at 27% gross margin, compared to second quarter of fiscal year 2026 gross profit of $58.2 million. • Diluted earnings per share increased 24% to $0.67, compared to second quarter of fiscal year 2026 diluted earnings per share of $0.54. • The Company exited the quarter with $270 million of cash, cash equivalents, and no borrowings. • The Company repurchased $18.1 million of common stock during the quarter. CorVel generated strong momentum in its workers' compensation and liability businesses through new customer wins and deeper relationships with existing clients. As employers and insurers face greater claim complexity, rising medical costs, and increasing administrative demands, the Company's integrated claims management and managed care model brings together clinical expertise, technology, and cost containment solutions to improve patient outcomes and manage total claim costs. Technology innovation remains central to CorVel's efforts to modernize claims administration and increase operational capacity. The integration of artificial intelligence into core claims workflows is reducing manual processes and providing adjusters with more timely, actionable information. Recent developments within Care MC and MyCare, a digital self-service portal, are improving communication and access to claim information. Within Network Solutions, the introduction of Marketwise Repricing TM provides a more sophisticated approach to out-of-network medical repricing, while investments in pharmacy benefits management strengthen pricing, network access, and clinical oversight. CERIS gained further traction among the nation's largest healthcare payers with the implementation of an additional Top 10 national health plan and a strategic partnership providing access to the Blue Cross Blue Shield market. Product development efforts include new Hospital Bill Audit and Professional Claims solutions, extending the scope of CERIS' prepayment services to address complex reimbursement challenges. Together, these initiatives position CERIS to deepen customer relationships, reach new markets, and deliver greater value to health plans seeking improved payment accuracy and control over healthcare expenditures. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved payment accuracy and reducing costs, improving program performance and achieving better outcomes with operational expertise combined with advanced technology. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement. The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2026, and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason. CorVel Corporation Quarterly Results – Income Statement Quarters and Six Months Ended September 30, 2026 (unaudited) and September 30, 2025 (unaudited)
CorVel Corporation Quarterly Results – Condensed Balance Sheet September 30, 2026 (unaudited) and March 31, 2026
Full text with the tables
Exhibit 99.1
Date: November 3, 2026 CorVel Corporation
───────────────────────────────────────────────────
5128 Apache Plume Road
Suite 400
Fort Worth, TX 76109
FOR IMMEDIATE RELEASE Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com
CorVel Announces Revenues and Earnings FORT WORTH, Texas, November 3, 2026 —
CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended
September 30, 2026. Revenues for the quarter were $267 million, an increase from
$240 million in the September quarter of 2025. Earnings per share for the
quarter were $0.67, compared to $0.54 in the same quarter of the prior year.
Revenues for the six months ended September 30, 2026 were $527 million, an
increase from $474 million for the six months ended September 30, 2025. Earnings
per share for the six months ended September 30, 2026 were $1.31, compared to
$1.06 during the six months ended September 30, 2025. Second Quarter Fiscal Year
2027 Highlights • Revenue increased 11% to $267 million, compared to second
quarter of fiscal year 2026. • Gross profit increased 24% to $72.3 million, at
27% gross margin, compared to second quarter of fiscal year 2026 gross profit of
$58.2 million. • Diluted earnings per share increased 24% to $0.67, compared to
second quarter of fiscal year 2026 diluted earnings per share of $0.54. • The
Company exited the quarter with $270 million of cash, cash equivalents, and no
borrowings. • The Company repurchased $18.1 million of common stock during the
quarter. CorVel generated strong momentum in its workers' compensation and
liability businesses through new customer wins and deeper relationships with
existing clients. As employers and insurers face greater claim complexity,
rising medical costs, and increasing administrative demands, the Company's
integrated claims management and managed care model brings together clinical
expertise, technology, and cost containment solutions to improve patient
outcomes and manage total claim costs. Technology innovation remains central to
CorVel's efforts to modernize claims administration and increase operational
capacity. The integration of artificial intelligence into core claims workflows
is reducing manual processes and providing adjusters with more timely,
actionable information. Recent developments within Care MC and MyCare, a digital
self-service portal, are improving communication and access to claim
information. Within Network Solutions, the introduction of Marketwise Repricing
TM provides a more sophisticated approach to out-of-network medical repricing,
while investments in pharmacy benefits management strengthen pricing, network
access, and clinical oversight. CERIS gained further traction among the nation's
largest healthcare payers with the implementation of an additional Top 10
national health plan and a strategic partnership providing access to the Blue
Cross Blue Shield market. Product development efforts include new Hospital Bill
Audit and Professional Claims solutions, extending the scope of CERIS'
prepayment services to address complex reimbursement challenges. Together, these
initiatives position CERIS to deepen customer relationships, reach new markets,
and deliver greater value to health plans seeking improved payment accuracy and
control over healthcare expenditures. Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995 All statements included in this press
release, other than statements or characterizations of historical fact, are
forward-looking statements. These forward-looking statements are based on the
Company’s current expectations, estimates and projections about the Company,
management’s beliefs, and certain assumptions made by the
Company, and events beyond the Company’s control, all of which are subject to
change. Such forward-looking statements include, but are not limited to,
improved payment accuracy and reducing costs, improving program performance and
achieving better outcomes with operational expertise combined with advanced
technology. These forward-looking statements are not guarantees of future
results and are subject to risks, uncertainties and assumptions that could cause
the Company’s actual results to differ materially and adversely from those
expressed in any forward-looking statement. The risks and uncertainties referred
to above include but are not limited to factors described in this press release
and the Company’s filings with the Securities and Exchange Commission, including
but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K
for the year ended March 31, 2026, and the Company’s Quarterly Report on Form
10-Q for the quarter ended June 30, 2026. The forward-looking statements in this
press release speak only as of the date they are made. The Company undertakes no
obligation to revise or update publicly any forward-looking statement for any
reason.
CorVel Corporation Quarterly Results – Income Statement Quarters and Six Months
Ended September 30, 2026 (unaudited) and September 30, 2025 (unaudited)
September 30, September 30,
Quarter Ended 2026 2025
──────────────────────────────────────────────────────────────────────────────
Revenues $ 267,129,000 $ 239,643,000
Cost of revenues 194,830,000 181,466,000
Gross profit 72,299,000 58,177,000
General and 26,454,000 22,277,000
administrative
Income from operations 45,845,000 35,900,000
Income tax provision 11,758,000 7,994,000
Net income $ 34,087,000 $ 27,906,000
Earnings Per Share:
Basic $ 0.67 $ 0.54
Diluted $ 0.67 $ 0.54
Weighted Shares
Basic 50,545,000 51,314,000
Diluted 50,690,000 51,723,000
September 30, September 30,
Six Months Ended 2026 2025
──────────────────────────────────────────────────────────────────────────────
Revenues $ 527,054,000 $ 474,354,000
Cost of revenues 386,961,000 359,552,000
Gross profit 140,093,000 114,802,000
General and 50,907,000 43,619,000
administrative
Income from 89,186,000 71,183,000
operations
Income tax provision 22,874,000 16,042,000
Net income $ 66,312,000 $ 55,141,000
Earnings Per Share:
Basic $ 1.31 $ 1.07
Diluted $ 1.31 $ 1.06
Weighted Shares
Basic 50,675,000 51,333,000
Diluted 50,809,000 51,817,000
CorVel Corporation Quarterly Results – Condensed Balance Sheet September 30,
2026 (unaudited) and March 31, 2026
September 30, 2026 March 31, 2026
──────────────────────────────────────────────────────────────────────────────
Cash $ 269,988,000 $ 233,072,000
Customer deposits 130,464,000 115,706,000
Accounts receivable, net 108,396,000 101,313,000
Prepaid taxes and 11,860,000 12,206,000
expenses
Property, net 124,418,000 117,906,000
Goodwill and other 42,779,000 41,619,000
assets
Right-of-use asset, net 25,692,000 21,146,000
Total $ 713,597,000 $ 642,968,000
Accounts and taxes $ 23,563,000 $ 24,550,000
payable
Accrued liabilities 233,889,000 203,518,000
Long-term lease 25,643,000 20,687,000
liabilities
Paid-in capital 279,042,000 268,518,000
Treasury stock (928,281,000 ) (887,716,000 )
Retained earnings 1,079,741,000 1,013,429,000
Total $ 713,597,000 $ 642,986,000